Livzon Pharmaceutical repurchases A-shares as buyback program continues

Livzon Pharmaceutical Group, traded on the Shenzhen Stock Exchange, announced its repurchase of 125,500 A-shares on September 17, 2025. The transaction was conducted through other securities exchanges at prices ranging from yuan 39.68 to yuan 40.08 per share, totaling yuan 4,999,175.

This latest buyback is part of ongoing repurchase activities. The company's total issued H-shares remained unchanged at 299,807,117 as of September 17, 2025. The total issued A-shares also remained at 604,293,313, as the repurchased shares are pending cancellation.

Livzon Pharmaceutical has been actively repurchasing A-shares since late 2024 and throughout 2025. The disclosure confirms that the repurchases comply with relevant listing rules and have been duly authorized by the board.